Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer

View the experts discuss the ins and outs of immunotherapy for advanced non-small cell lung cancer (NSCLC) in the real world. Credit available for this activity expires: 11/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998874?ecd=bdc_podcast_libsyn_mscpedu